{"ModuleTitle": "Company Description", "CompanyName": "Insulet Corporation", "Symbol": "PODD", "Address": "100 NAGOG PARK, ACTON, Massachusetts, 01720, United States of America", "Phone": "978-600-7000", "Industry": "Medical/Dental Instruments", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "Insulet Corporation (\"we\" or the \"Company\") is primarily engaged in the\r\ndevelopment, manufacture and sale of its proprietary Omnipod\u00ae System, an\r\ninnovative, discreet and easy-to-use continuous insulin delivery system for\r\npeople with insulin-dependent diabetes, which we have been selling since 2005.\r\nThe Omnipod System consists of the following: the Omnipod Insulin Management\r\nSystem (\"Omnipod\") and the Omnipod DASHTM Insulin Management System (\"Omnipod\r\nDASH\" or \"DASH\"), our next generation digital mobile Omnipod platform.\r\n\r\nThere are two primary types of insulin therapy practiced today: multiple daily\r\ninjection (\"MDI\") therapy using syringes or insulin pens; and pump therapy using\r\ninsulin pumps. Insulin pumps are used to perform continuous subcutaneous insulin\r\ninfusion and typically use a programmable device and an infusion set to\r\nadminister insulin into the person's body.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f02%2f26%2f0001145197-20-000004.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "Charles Alpuche", "title": "Chief Operations Officer & Executive VP"}, {"name": "Shacey Petrovic", "title": "President, Chief Executive Officer & Director"}, {"name": "Trang Ly", "title": "Vice President & Medical Director"}, {"name": "Wayde Dwight McMillan", "title": "Chief Financial Officer, Treasurer & EVP"}], "Number_of_employees": ["NO INFO"], "Subsidiaries": ["NO INFO"]}